Circulating microRNAs as Disease Markers in Pediatric Cancers

Clinical Trial ID NCT01541800

PubWeight™ 2.79^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01541800

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer.	Gynecol Oncol	2008	11.46
2	Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma.	Br J Haematol	2008	10.28
3	Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening.	Gut	2009	8.98
4	Circulating microRNAs, potential biomarkers for drug-induced liver injury.	Proc Natl Acad Sci U S A	2009	6.91
5	Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer.	Int J Cancer	2010	5.57
6	Plasma miR-208 as a biomarker of myocardial injury.	Clin Chem	2009	3.61
7	Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction.	Biochem Biophys Res Commun	2009	3.49
8	Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer.	Breast Cancer Res	2010	2.98
9	Circulating microRNAs in breast cancer and healthy subjects.	BMC Res Notes	2009	2.78
10	MicroRNAs as Novel Biomarkers for Breast Cancer.	J Oncol	2009	1.72
11	MicroRNA patterns associated with clinical prognostic parameters and CNS relapse prediction in pediatric acute leukemia.	PLoS One	2009	1.62
12	Global population-specific variation in miRNA associated with cancer risk and clinical biomarkers.	BMC Med Genomics	2014	1.13
13	MicroRNAs and Potential Targets in Osteosarcoma: Review.	Front Pediatr	2015	0.98
14	Normal and oncogenic roles for microRNAs in the developing brain.	Cell Cycle	2009	0.86
15	Oligometastatic disease, the curative challenge in radiation oncology.	World J Clin Oncol	2015	0.75